Artivion | CRY - 销售收入

股票价格

35.29

每天变化

-1.10 -3.02%

每月一次

-8.46%

每年

45.53%

Q1 预测

35.04

金融业

USD

USD 884.8M

现金及等价物

USD 64.91M

USD 42.85M

USD 358.08M

USD 101.56M

USD 317.78M

USD 4.79M

USD 22.72M

1.5K

EPS每股收益

USD -0.02

股本和储备

USD 448.23M

USD 73.14M

债务利息支出

USD 5.53M

USD -0.05

USD 217.81M

USD 1.46B

USD 2.42M

USD 111.2M

USD 4.79M

普通股股本

USD 47.84M

212.38

USD 11.4M

USD 115.99M

销售和管理费用

USD 55.75M

USD 92.43M

贸易债权人

USD 16.04M

应收帐款人

USD 103.68M

	销售	更改		日
Abbott	USD 11.46B		90M	2025-12
Accuray	USD 116.17M		14.63M	2024-12
AngioDynamics	USD 79.43M		3.72M	2025-09
Artivion	USD 115.99M		2.6M	2025-12
AtriCure	USD 140.5M		6.2M	2025-12
Baxter International	USD 2.97B		130M	2025-12
Becton, Dickinson and Co.	USD 5.3B		600M	2025-12
Boston Scientific	USD 5.29B		220M	2025-12
Edwards Lifesciences	USD 1.57B		20M	2025-12
Inogen	USD 74.93M		504K	2024-09
Integra LifeSciences	USD 434.9M		32.84M	2025-12
J&J	USD 24.6B		610M	2025-12
Mesa Laboratories	USD 62.84M		5.01M	2024-12
Orthofix International	USD 219.91M		14.28M	2025-12
Pfizer	USD 17.58B		880M	2025-12
ResMed	USD 1.4B		100M	2025-12
Stryker	USD 7.2B		1.14B	2025-12
Surmodics	USD 29.92M		96.16M	2024-12
Tandem Diabetes Care	USD 290.4M		41.15M	2025-12
Teleflex	USD 568.98M		344.02M	2025-12
Terumo	JPY 296.63B		21.66B	2025-12
Trinity Biotech	USD 14.31M		1.55M	2025-09